US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on May 26 for "Molecular subtyping of small cell lung cancer to predict therapeutic responses" (Texas Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,720, issued on May 26, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Molecular subtyping of small cell lung cancer to predict therapeutic responses" was invented by Carl M. Gay (Houston), Lauren A. Byers (Houston) and John V. Heymach (Houston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods for determining a subtype of a small cell lung cancer in a patient based on the express status of ASCL1, NEUROD1, and POU2F3, which are expressed in a mutually exclusive fashion. The subtype of the cancer can be used to determine the sensitivity of the cancer to certain anti-cancer therapies. As such, ...